Navigation Links
ChromaDex Announces Financial Results for Second Quarter 2011
Date:8/11/2011

ers for the quarter ended July 2, 2011 was $1,842,569 as compared to a net loss of $303,529 for the same period in 2010. The net loss in the second quarter of 2011 was significantly impacted by an increase in non-cash, share-based compensation expense related to the stock options that were granted following the May 20, 2010 private placement and the restricted stock that was issued to certain employees and consultants. When the net loss is adjusted to exclude the effects of non-cash charges associated with share-based compensation expense, a "non-GAAP" presentation, the net loss for the second quarter of 2011 is $1,073,864 and the loss per share for the second quarter of 2011 is $0.02.

About ChromaDexChromaDex is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries. The company has an impressive pipeline of new ingredients, including its pTeroPure brand on which it has worldwide, exclusive patent rights.

ChromaDex Forward-Looking StatementsAny statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the effect of economic conditions both nationally and internationally, ability to protect our intellectual property rights, impact of any litigation or infringement actions brought against us, competition from other providers and products, risks in product development, our ability to raise capital to fund continuing operations, the ability to complete transactions, and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to upda
'/>"/>

SOURCE ChromaDex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ChromaDex Partners With Kappa Bioscience to Provide Quality Control Methods, Tools and Services for Vitamin K2
2. ChromaDex and Bruker Optics Sign Agreement to Expedite Dietary Supplement Testing for Compliance With FDA Good Manufacturing Practice Requirements
3. Nutraceutical International Corporation Launches Product Featuring ChromaDexs pTeroPure™ Pterostilbene
4. Life Extension® Launches New Product Containing ChromaDexs pTeroPure® Pterostilbene
5. ChromaDex Licenses Additional Technology for pTeroPure® From the University of Mississippi
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015  Research ... addition of the "An Introduction to the ... 2015)" conference to their offering. ... the European medical device legislation. It will explain ... involvement of Notified Bodies, how to choose one ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has announced the ... UK - November 16-17, 2015)" conference to their ... concerning Pharmacovigilance are a major departure in terms of ... . The intention of the course is to ... they overlap and fit together and what Companies need ...
(Date:9/2/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report "Therapeutic Drug ... their offering. This report deals with ... at improving patient care by monitoring drug levels ... of drugs for improving outcome. TDM is viewed ...
Breaking Medicine Technology:Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024 2
... FRANCISCO, Oct. 18, 2011 ClinStar, LLC , ... and Eastern Europe to the pharmaceutical and biotechnology industry, ... Manager of Clinical Operations Alexander Kutermin will speak at ... Regions conference, November 3-4, in Philadelphia, PA.   ...
... Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing ... cancer, announced today that it will begin accepting ... (ELLSA™) from researchers that require a highly sensitive ... in cell culture, ascites, and other biological fluids, ...
Cached Medicine Technology:ClinStar to Present on Clinical Trial Recruitment in the Emerging Regions of Russia and Eastern Europe 2Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community 2Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community 3
(Date:9/2/2015)... ... September 02, 2015 , ... Splashtop ... latest addition to its screen mirroring and extending product line -- Splashtop ... which operates in local WIFI setting, the new Splashtop Wired XDisplay delivers enhanced ...
(Date:9/2/2015)... ... September 02, 2015 , ... Michael Elliot Media announces ... a plus-size actress as the primary love interest in the film. The campaign is ... film, significantly affects how and what we think,” Michael Elliot, an award-winning screenwriter and ...
(Date:9/2/2015)... ... ... Ericson is a noted speaker and educator in the field of CDI and ... the Association for Clinical Documentation Improvement Specialists (ACDIS) where she developed and led the ... a CDI subject matter expert for a variety of HCPro and ACDIS publications and ...
(Date:9/2/2015)... Florida (PRWEB) , ... September 02, 2015 , ... A ... drug prices over the past year and its negative impact on consumers. It was ... prescription medication and 10% were paying as much as an extra $100 compared to ...
(Date:9/2/2015)... ... September 02, 2015 , ... EDAC ... and case management solutions and services to both government and commercial clients, today ... Image Clean-up utility for IBM’s Datacap document capture platform. EDAC PurePAGE processes ...
Breaking Medicine News(10 mins):Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3
... risk of deaths related to heart disease, study shows , ... flu may be at higher risk for having a heart ... report. , Because both seasonal and the pandemic H1N1 swine ... for heart attacks are urged to get a seasonal flu ...
... has found that switching post-menopausal women with early breast cancer ... of tamoxifen rather than keeping them on tamoxifen for five ... the risk of death for at least the next six ... of switching to exemestane mid-way through the five-year tamoxifen treatment ...
... most women experience minor pain during menstruation, for others, ... everyday activities and require medication. New research to be ... (AAPS) Annual Meeting and Exposition will reveal initial findings ... effectively treat menstrual pain. "The goal of our ...
... In ... does this condition lead to discomfort and embarrassment, it also negatively impacts daily routines. Irregular ... not normal--it is a recognized medical condition for which they can seek treatment. , ... Phoenix, AZ (Vocus/PRWEB) September 20, 2009. ...
... 21 In a bid to help underserved children, ... Ysio Digital Radiology System. As the winning online bidder, John ... check for $285,309. , , See video from ... http://inr.mediaseed.tv/oneClip_C/?feed=hK4UKEtcAILqy08qpCX6wBwEMnTvqjZg , , Last winter, hospitals ...
... , , SACRAMENTO, Calif., ... the Twin Rivers Unified School District will be able to ... created jointly by the California Dental Association Foundation, University of ... California HealthCare Foundation with start-up funding from Verizon. , ...
Cached Medicine News:Health News:Flu Can Raise Chances of Heart Attack 2Health News:Flu Can Raise Chances of Heart Attack 3Health News:Switching early breast cancer patients to exemestane improves long-term survival 2Health News:New device could more effectively alleviate menstrual cramp pain 2Health News:Endometrial Ablation Offers Relief for Abnormally Heavy or Irregular Menstrual Bleeding 2Health News:Endometrial Ablation Offers Relief for Abnormally Heavy or Irregular Menstrual Bleeding 3Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 2Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 3Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 4
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
... II CPAP has sound absorption materials ... consistent pressure. The backlit silicone buttons ... easy, and the interface to set ... simple. This CPAP device comes with ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
The S7 Lightweight offers the comfort and reliability of the award-winning S7 series in a convenient, affordable device....
Medicine Products: